Baoji Pharmaceutical is a biopharma R&D manufacturer, a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production.
Baoji Pharmaceutical is a biopharma R&D manufacturer and a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production. Baoji Pharmaceutical has established "recombinant human hyaluronidase-based subcutaneous drug delivery technology" and "pharmaceutical equipment required by assisted reproductive" as the core of its two key research and development directions. The company has established three core technology platforms, including a "medicinal enzyme engineering technology center," a "glycoprotein drug engineering technology center," and an "antibody targeting enzyme engineering technology center."
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 25, 2022 | Series B | $100M | 6 | Oriental Fortune Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Oriental Fortune Capital | Yes | Series B |
CenterLab | — | Series B |
Findowin Capital | — | Series B |
Haitong Innovation Capital Management | — | Series B |
Jingtong Equity Investment | — | Series B |
Sun Rock Capital | — | Series B |